http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-229766-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
filingDate 2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-229766-A0
titleOfInvention A combination of panobinostat and roxolitinib for the treatment of cancer such as myeloproliferative cancer
priorityDate 2011-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25126798

Total number of triples: 17.